Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Long-Term Investments (2021 - 2025)

Zymeworks' Long-Term Investments history spans 5 years, with the latest figure at $41.8 million for Q4 2025.

  • On a quarterly basis, Long-Term Investments fell 57.55% to $41.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.8 million, a 57.55% decrease, with the full-year FY2025 number at $41.8 million, down 57.55% from a year prior.
  • Long-Term Investments hit $41.8 million in Q4 2025 for Zymeworks, down from $47.4 million in the prior quarter.
  • Over the last five years, Long-Term Investments for ZYME hit a ceiling of $98.4 million in Q4 2024 and a floor of $886000.0 in Q4 2021.
  • Historically, Long-Term Investments has averaged $57.3 million across 5 years, with a median of $65.8 million in 2024.
  • Biggest five-year swings in Long-Term Investments: surged 10698.42% in 2023 and later tumbled 57.55% in 2025.
  • Tracing ZYME's Long-Term Investments over 5 years: stood at $886000.0 in 2021, then changed by 0.0% to $886000.0 in 2022, then surged by 9147.18% to $81.9 million in 2023, then grew by 20.14% to $98.4 million in 2024, then plummeted by 57.55% to $41.8 million in 2025.
  • Business Quant data shows Long-Term Investments for ZYME at $41.8 million in Q4 2025, $47.4 million in Q3 2025, and $52.0 million in Q2 2025.